Tags:
Filed under: Events
In what might perhaps be a landmark judgement, the United States Supreme Court denied a patent to Myriad Genetics; the product: human genes. The background: The company, Myriad Genetics, had successfully isolated a gene that pointed towards the increased risk of hereditary breast and ovarian cancer among women. The company was able to discover the precise location of the critical genes: BRCA1 and BRCA2 and this allowed the firm to create tests that no other firm could offer. Moreover, the ...